These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels. Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401 [TBL] [Abstract][Full Text] [Related]
29. Activation of Melatonin Receptors by Ramelteon Induces Cardioprotection by Postconditioning in the Rat Heart. Stroethoff M; Behmenburg F; Spittler K; Raupach A; Heinen A; Hollmann MW; Huhn R; Mathes A Anesth Analg; 2018 Jun; 126(6):2112-2115. PubMed ID: 29381514 [TBL] [Abstract][Full Text] [Related]
30. Ramelteon for the treatment of insomnia. Borja NL; Daniel KL Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111 [TBL] [Abstract][Full Text] [Related]
31. Autoimmune hepatitis in association with ramelteon. Fourman LT; Robert Meyer B J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362 [TBL] [Abstract][Full Text] [Related]
33. Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study. Torii H; Shimizu R; Tanizaki Y; Omiya Y; Yamamoto M; Kamiike S; Yasuda D; Hiraoka Y; Hashida T; Kume N Biol Pharm Bull; 2018; 41(12):1778-1790. PubMed ID: 30504680 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of M-II, the major human metabolite of ramelteon. Nishiyama K; Nishikawa H; Kato K; Miyamoto M; Tsukamoto T; Hirai K Pharmacology; 2014; 93(3-4):197-201. PubMed ID: 24923230 [TBL] [Abstract][Full Text] [Related]
35. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response. Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188 [TBL] [Abstract][Full Text] [Related]
36. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients. Mo Y; Scheer CE; Abdallah GT J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575 [TBL] [Abstract][Full Text] [Related]
37. Melatonin receptor agonists for treating delirium in elderly patients with acute stroke. Ohta T; Murao K; Miyake K; Takemoto K J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1107-10. PubMed ID: 23017429 [TBL] [Abstract][Full Text] [Related]
38. Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat. Mathes AM; Kubulus D; Waibel L; Weiler J; Heymann P; Wolf B; Rensing H Crit Care Med; 2008 Oct; 36(10):2863-70. PubMed ID: 18766086 [TBL] [Abstract][Full Text] [Related]
39. Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer. Moreno-SanJuan S; Puentes-Pardo JD; Casado J; Escudero-Feliu J; Khaldy H; Arnedo J; Carazo Á; León J Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107301 [TBL] [Abstract][Full Text] [Related]
40. Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy. Petronek MS; Stolwijk JM; Murray SD; Steinbach EJ; Zakharia Y; Buettner GR; Spitz DR; Allen BG Redox Biol; 2021 Jun; 42():101864. PubMed ID: 33485837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]